Bruker Cellular Analysis
在场
Bruker Cellular Analysis 的所有者是 Bruker.
是其中之一......
Bruker 是一家在股票代码 BRKR (US) 下上市的公司。
Bruker 在 2 个国家有直接业务。Bruker 拥有 3家子公司，其中包括 Bruker Cellular Analysis、Jordan Valley 和 JPK Instruments。
他们在：
涉及Bruker的并购和融资。
- Bruker Cellular Analysis 已收购 Isoplexis (公布2022十二月29号).
高管
查看带有其 6 名主要高管的组织结构图
Bruker Cellular Analysis 搜索最多的简介
- Yan Zhang, President
- Mehul Joshi, Chief Financial Officer
- Eric Hobbs, President, Antibody Therapeutics
高管在Bruker变化
- Philip Ma, Director, 已经离开公司 (新闻发布的2024八月8号).
创建提醒
跟踪 Bruker Cellular Analysis 的高管变动
生物技术
Bruker 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Bruker Cellular Analysis 的最新新闻稿
- PhenomeX Inc. - Login
- PhenomeX Inc. - PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
- PhenomeX Inc. - PhenomeX to Participate in Upcoming Cell Biology Conferences
- PhenomeX Inc. - PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics
- PhenomeX Inc. - PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
- PhenomeX Inc. - Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
- PhenomeX Inc. - PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update
- PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case
- PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023
- PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies
- View more press releases Close
通过电子邮件
